BE815405A - Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity - Google Patents
Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activityInfo
- Publication number
- BE815405A BE815405A BE144632A BE144632A BE815405A BE 815405 A BE815405 A BE 815405A BE 144632 A BE144632 A BE 144632A BE 144632 A BE144632 A BE 144632A BE 815405 A BE815405 A BE 815405A
- Authority
- BE
- Belgium
- Prior art keywords
- alkyl
- atom
- subst
- atoms
- opt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
(A) Cpds. of formula (I) and their acid-addition salts are new (where R' is H, alkyl, 3-6C cycloalkyl, phenyl opt. subst. by halogen, alkyl, alkoxy; R2 is H, Cl, Br, formyl acetyl, NH2, NO2, alkyl dialkylaminomethyl or the group -NH.CO.A where A is H or alkyl opt. subst. by halogen; R3 is H, OH, alkyl, 3-6C cycloalkyl, phenyl opt. subst. by halogen, alkyl, alkoxy; R4 is H, alkyl, alkenyl or alkynyl where the multiple bond is not alpha to the N-atom, hydroxyalkyl or alkoxyalkyl where the O-atom is separated from the N-atom by at least two C-atoms; dialkylaminoalkyl in which the N-atoms are separated by at least two C-atoms; 3-7C cycloalkyl, 4-10C cycloalkylalkyl, pyridyl, pyrimidyl, benzyl (opt. subst. in the aryl part by halogen, OH, alkyl, alkoxy), NH2, dialkylamino, 2-7C alkyleneimino; R5 is H, alkyl, alkenyl or alkynyl where the multiple bond is not alpha to the N-atom to which the group is attached, hydroxyalkyl or alkoxyalkyl where the O-atom is separated from the N-atom by at least two C-atoms, dialkylaminoalkyl where the two N-atoms are separated by at least two C-atoms, 3-7C cycloalkyl, 4-10C cycloalkylalkyl; or R4 and R5 together with the attached N-atom form piperidino, pyrrolidino, morpholino, thiomorpholino, or a group N4-B-(1-piperazinyl) where B is alkyl or hydroxyalkyl where the OH group is separated from the N4-atom by at least 2 C-atoms; or phenyl opt. subst. by halogen, alkyl, alkoxy; the group A opt. present in the group R2 must be H, Me or Et when R4, R5 are both H). (B) Cpds. of formula (II) are also new: (where R' is as in I; R2a is H Cl, Br, NO2, alkyl; R3a is H, alkyl, 3-6C cycloalkyl, phenyl opt. subst. by halo, alkyl, alkoxy; X is OH or the group SR6 where R6 is H, alkyl, 3-6C cycloalkyl, benzyl, opt. subst. by OH, alkyl, alkoxy or halogen on the benzene ring.) (I) and (II) are bronchospasmolytics; acute LD50 (p.o.rat) is typically >=100mg/kg. (II) are also inters. to (I).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH725773 | 1973-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE815405A true BE815405A (en) | 1974-11-22 |
Family
ID=4322305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE144632A BE815405A (en) | 1973-05-22 | 1974-05-22 | Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE815405A (en) |
ZA (1) | ZA743316B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246932A (en) * | 1991-05-23 | 1993-09-21 | Imperial Chemical Industries Plc | Heterocyclic compounds |
US5290776A (en) * | 1991-05-23 | 1994-03-01 | Imperial Chemical Industries, Plc | Azole derivatives |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0459702A1 (en) * | 1990-05-29 | 1991-12-04 | Zeneca Limited | Azole Derivatives |
-
1974
- 1974-05-22 BE BE144632A patent/BE815405A/en unknown
- 1974-05-22 ZA ZA00743316A patent/ZA743316B/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246932A (en) * | 1991-05-23 | 1993-09-21 | Imperial Chemical Industries Plc | Heterocyclic compounds |
US5290776A (en) * | 1991-05-23 | 1994-03-01 | Imperial Chemical Industries, Plc | Azole derivatives |
Also Published As
Publication number | Publication date |
---|---|
ZA743316B (en) | 1976-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2230366A1 (en) | Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity | |
ES8203364A1 (en) | Aniline derivatives. | |
ES2014523A6 (en) | Aryl-heteroaryl-carbinol derivatives having an analgesic activity. | |
IE44280L (en) | 2,3-DIHYDRO-IMIDAZO [2,1-b] THIAZOLES HAVING ANALGESIC AND¹ANTI-INFLAMMATORY ACTIVITY | |
DE3585980D1 (en) | HYDRAZINE DERIVATIVES AND THEIR USE. | |
PT80507A (en) | NEW SUBSTITUTED BIS- (4-AMINOPHENYL) -SULFONES THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | |
BE815405A (en) | Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity | |
SE7703068L (en) | NEW SULPHONAMIDO BENZOIC ACID DERIVATIVES LIKE THEIR PREPARATION | |
DE69127072D1 (en) | SUBSTITUTED UREAS, PRODUCTION AND USE | |
ES2058247T3 (en) | 4-HYDROXYCINNOLIN-CARBOXAMIDES, ITS USE AND METHOD OF PREPARATION. | |
ES450070A1 (en) | Thiazolidine derivatives | |
SE7609909L (en) | NEW PENICILLINES AND PROCEDURES FOR MANUFACTURING THEM | |
DE3061188D1 (en) | 2-sulfonyl-quinoxalines, processes for their preparation and their use as microbicides | |
ES8602698A1 (en) | Novel quinazolinone derivative, a process for preparing the same and a pharmaceutical composition. | |
ES8400384A1 (en) | Carbacyclines, process for their preparation and their use as medicines. | |
IE800900L (en) | Pyrrolidinyl-benzoic acid derivatives. | |
ATE79754T1 (en) | MEDICATIONS CONTAINING DIOXOPIPERIDE INDIVIDUALS TO IMPROVE MEMORY. | |
SE7601592L (en) | METHOD OF MANUFACTURE IMIDAZOLE BENZODIAZEPINES | |
FR2150594A1 (en) | Omega-amino-1,2-diphenyl-1-alkanones - with analgesic antiinflammatory anti-ulcer,bronchodilator,spasmolytic and hypotensive | |
ATE81003T1 (en) | ANTI-SYCHOTIC COMPOSITIONS WITH DIOXOPIPERIDINE DERIVATIVES. | |
FR2244514A1 (en) | 1,2-Dihydroquinoline derivs - useful as anti-inflammatories | |
FR2333510A2 (en) | 1-Aroylethyl 2-piperazinomethyl benzimidazoles - useful eg for treatment of ulcers, asthma, hypertension, oedemand pain | |
FR2338044A1 (en) | Glycero-phosphates of papaverine and ethaverine - have same musculotropic spasmolytic activity as free bases and hydrochlorides, but higher solubility | |
FR2323378A1 (en) | Antiarrhythmic dialkyl amino alkyl benzamidines - prepd. from a benzamidine and a primary tertiary alkylene diamine | |
FR2236494A1 (en) | N-(1,2,6,7,8,8a-hexahydro-benzo(c,d)-indole-1-yl)-guanidines - as salidiuretic agents |